[go: up one dir, main page]

GB1290141A - - Google Patents

Info

Publication number
GB1290141A
GB1290141A GB1290141DA GB1290141A GB 1290141 A GB1290141 A GB 1290141A GB 1290141D A GB1290141D A GB 1290141DA GB 1290141 A GB1290141 A GB 1290141A
Authority
GB
United Kingdom
Prior art keywords
vaccines
toxoid
welchii
polyornithine
polyarginine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of GB1290141A publication Critical patent/GB1290141A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55516—Proteins; Peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)

Abstract

1290141 Vaccines WELLCOME FOUNDATION Ltd 29 Aug 1969 [31 May 1968] 26115/ 68 Heading A5B [Also in Divisions C2 and C3] Vaccines comprise a non-pathogenic antigenic material and, as adjuvant, a base-rich peptide in which at least 50% of the residues have free amino groups. Examples thereof include polylysine, polyornithine, polyarginine and polydiaminobutyric acid. Antigenic materials referred to include diphtheria toxoid, tetanus toxoid, calf pneumonia virus and Cl. welchii epsilon toxoid. Reference is also made to various viral, bacterial and protozoal vaccines.
GB1290141D 1968-05-31 1968-05-31 Expired GB1290141A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB2611568 1968-05-31

Publications (1)

Publication Number Publication Date
GB1290141A true GB1290141A (en) 1972-09-20

Family

ID=10238613

Family Applications (1)

Application Number Title Priority Date Filing Date
GB1290141D Expired GB1290141A (en) 1968-05-31 1968-05-31

Country Status (1)

Country Link
GB (1) GB1290141A (en)

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0038153A3 (en) * 1980-04-15 1982-12-22 Beecham Group Plc Modified allergens
FR2577139A1 (en) * 1985-02-10 1986-08-14 Israel Mini Agricult VACCINE COMPOSITION AND METHOD OF PREPARATION
DE19638313A1 (en) * 1996-09-19 1998-04-02 Boehringer Ingelheim Int Composition containing immunomodulatory peptide or protein and adjuvant
US6166217A (en) * 1998-02-09 2000-12-26 Alliedsignal Inc. Process for the production of alkoxycarbonyldipeptides intermediates in the synthesis of the lisinopril
WO2000056361A3 (en) * 1999-03-24 2001-03-01 Secr Defence Vaccine composition
AT408721B (en) * 1999-10-01 2002-02-25 Cistem Biotechnologies Gmbh PHARMACEUTICAL COMPOSITION CONTAINING AN ANTIG
WO2002053185A3 (en) * 2001-01-05 2002-10-31 Intercell Biomedizinische Forschungs & Entwicklungs Gmbh Anti-inflammatory use of polycationic compounds
US7105162B1 (en) 1996-02-24 2006-09-12 Boehringer Ingelheim International Gmbh Pharmaceutical composition for immunomodulation based on peptides and adjuvants
US7244438B2 (en) 2001-01-05 2007-07-17 Intercell Ag Uses for polycationic compounds
US20170014350A1 (en) * 2015-07-16 2017-01-19 University-Industry Foundation, Yonsei University Oral virus vaccine

Cited By (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0038153A3 (en) * 1980-04-15 1982-12-22 Beecham Group Plc Modified allergens
FR2577139A1 (en) * 1985-02-10 1986-08-14 Israel Mini Agricult VACCINE COMPOSITION AND METHOD OF PREPARATION
US7105162B1 (en) 1996-02-24 2006-09-12 Boehringer Ingelheim International Gmbh Pharmaceutical composition for immunomodulation based on peptides and adjuvants
DE19638313A1 (en) * 1996-09-19 1998-04-02 Boehringer Ingelheim Int Composition containing immunomodulatory peptide or protein and adjuvant
DE19638313C2 (en) * 1996-09-19 2000-05-31 Boehringer Ingelheim Int Pharmaceutical composition for immunomodulation
US6166217A (en) * 1998-02-09 2000-12-26 Alliedsignal Inc. Process for the production of alkoxycarbonyldipeptides intermediates in the synthesis of the lisinopril
AU762078B2 (en) * 1999-03-24 2003-06-19 Secretary Of State For Defence, The Vaccine composition
WO2000056361A3 (en) * 1999-03-24 2001-03-01 Secr Defence Vaccine composition
AT408721B (en) * 1999-10-01 2002-02-25 Cistem Biotechnologies Gmbh PHARMACEUTICAL COMPOSITION CONTAINING AN ANTIG
EP2269643A2 (en) 1999-10-01 2011-01-05 Intercell AG Hcv vaccine compositions
EP2269642A2 (en) 1999-10-01 2011-01-05 Intercell AG Hcv vaccine compositions
EP2269640A2 (en) 1999-10-01 2011-01-05 Intercell AG Hcv vaccine compositions
EP2269641A2 (en) 1999-10-01 2011-01-05 Intercell AG Hcv vaccine compositions
US8277815B2 (en) 1999-10-01 2012-10-02 Intercell Ag Pharmaceutical composition comprising an antigen
WO2002053185A3 (en) * 2001-01-05 2002-10-31 Intercell Biomedizinische Forschungs & Entwicklungs Gmbh Anti-inflammatory use of polycationic compounds
US7244438B2 (en) 2001-01-05 2007-07-17 Intercell Ag Uses for polycationic compounds
US20170014350A1 (en) * 2015-07-16 2017-01-19 University-Industry Foundation, Yonsei University Oral virus vaccine
US10136662B2 (en) * 2015-07-16 2018-11-27 University-Industry Foundation, Yonsei University Oral virus vaccine

Similar Documents

Publication Publication Date Title
GB1290141A (en)
ES408766A1 (en) Process for preparing vaccine adjuvant
ES8202584A1 (en) Stabilizer for liquid vaccines and liquid vaccine containing said stabilizer.
LU91596I2 (en) Combination of diphtheria toxoid, tetanus toxoid, pertussis antoxin, filamentous hemagglutinin, pertactin, inactivated poliovirus type 1, type 2 and type 3 and capsular polysaccharide of haemophilus influenzae type b (Infanrix - IPV / Hib)
HUP9904287A1 (en) Acellular pertussis vaccine with diphtheriae- and tetanus-toxoids
GB1422973A (en) Process for preparing adsorbed vaccines
SE324208B (en)
GB1292803A (en) Improvements relating to the production of antigens
GB1256456A (en) Ethylethyleneimine as inactivating agent in antigen-containing pharmaceutical preparations
JPS5527178A (en) Live influenza virus vaccine
GB1413614A (en) Virus production
NZ192270A (en) Attenuated strain of feline infectious peritonitis virus and vaccine
GB1488800A (en) Influenza vaccines
OA09863A (en) Use of IL-4 to enhance immune response to immunogens in vaccines.
GB1256457A (en) Diethylaminoethyldextran (deae-d) as adjuvant for vaccines for active immunisation
ZA805849B (en) Process for the preparation of novel influenza virus strains and influenza virus vaccines containing them
GB1089767A (en) Vaccine adjuvants
PT69953A (en) Process for preparing a composition comprising a lyophilized herpes virus
GB1436323A (en) Cell and virus culture systems
GB1449606A (en) Vaccine preparation
GB1498821A (en) Vaccines
GB1212886A (en) Equine vaccine and vaccination treatment
GB1439742A (en) Live influenza type b virus vaccines and preparation thereof
IE853109L (en) Vaccines against avian infectious bronchitis
GR3020495T3 (en) Two-phase system for the production and presentation of foreign antigens in hybrid live vaccines

Legal Events

Date Code Title Description
PS Patent sealed
PCNP Patent ceased through non-payment of renewal fee